HomeInsightsPB

Parenteral Drugs (india) Ltd PB Ratio

Parenteral Drugs (india) Ltd PB Ratio

stocks purchased

₹ 0.0 Cr

Volume Transacted

(Aug 21, 2023)

stocks purchased

1.3 K

Stocks Traded

(Aug 21, 2023)

Last Updated on: Nov 14, 2024

Image

Parenteral Drugs (India) Ltd

NSE: PDPL

PB

-

Last updated on: Aug 21, 2024

Key Highlights

  • The P/B Ratio of Parenteral Drugs (India) Ltd is 0 as of 21 Aug 23.

Company Fundamentals for Parenteral Drugs (India) Ltd

Market Cap

10 Cr

EPS

0.0

P/E Ratio (TTM) *

0.0

P/B Ratio (TTM) *

0.0

Day’s High *

3.39

Day’s Low

3.08

DTE *

-0.1

ROE *

15.6

52 Week High

3.39

52 Week Low

0.0

ROCE *

7.7

Market Price Over Time

1M

1Y

3Y

5Y

Monitoring Parenteral Drugs (India) Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Aug 20233.39
14 Aug 20233.24
24 Jul 20233.09
17 Jul 20233.25
10 Jul 20233.42
03 Jul 20233.59
26 Jun 20233.77
19 Jun 20233.96
12 Jun 20233.85
05 Jun 20234.05

SWOT Analysis Of Parenteral Drugs (India) Ltd

Strength

0

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Parenteral Drugs (India) Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Parenteral Drugs (India) Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/B Ratio

Key Valuation Metric of Parenteral Drugs (India) Ltd

Share Price

₹3

PB Ratio

The price-to-book (P/B) ratio compares a company's market capitalization to its book value by dividing its stock price per share by its book value per share.


How to calculate Price-to-Book (P/B) Ratio?

The Price-to-Book Ratio is used to determine the relationship between the total value of a company's outstanding shares and the net value of its assets. Before calculating the P/B ratio, investors need to overlook the market capitalization of a company.


Market capitalization = market value of a stock X no. of outstanding shares


Now, you need to know the net value of an organization's assets.

Book Value of Assets = Total Assets - Total Liabilities of a company


After knowing the value of the above ratios, here is the formula for the P/B Ratio:

P/B Ratio = Market Capitalization/ Book Value of Assets


or you can also use this formula

P/B ratio = Market Price Per Share/ Book Value of Asset Per Share

Historical Market Cap of Parenteral Drugs (India) Ltd

No data available

* All values are in crore

Historical Revenue of Parenteral Drugs (India) Ltd

No data available

* All values are in crore

Historical EBITDA of Parenteral Drugs (India) Ltd

No data available

* All values are in crore

Historical Net Profit of Parenteral Drugs (India) Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Parenteral Drugs (India) Ltd News Hub

News

Parenteral Drugs (India) to conduct board meeting

Parenteral Drugs (India) will hold a meeting of the Board of Directors of the Company on 3...

Read more

19 May 202215:25

News

Parenteral Drugs (India) schedules board meeting

Parenteral Drugs (India) will hold a meeting of the Board of Directors of the Company on 1...

Read more

05 Feb 202215:19

News

Parenteral Drugs (India) to convene EGM

Parenteral Drugs (India) announced that an Extra Ordinary General Meeting (EGM) of the Com...

Read more

03 Feb 202216:49

News

Parenteral Drugs (India) schedules board meeting

Parenteral Drugs (India) will hold a meeting of the Board of Directors of the Company on 2...

Read more

31 Jan 202211:36

News

Parenteral Drugs (India) to hold board meeting

Parenteral Drugs (India) will hold a meeting of the Board of Directors of the Company on 1...

Read more

06 Nov 202116:34

News

Parenteral Drugs (India) AGM scheduled

Parenteral Drugs (India) announced that the 37th Annual General Meeting (AGM) of the compa...

Read more

27 Aug 202114:27

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PB Ratio of Parenteral Drugs (India) Ltd

What is the PB ratio of Parenteral Drugs (India) Ltd?

The current PB ratio of Parenteral Drugs (India) Ltd is 0.0. The Price-to-Book value (P/B) ratio compares a company's current share price to its book value per share. It helps assess whether a stock is overvalued or undervalued relative to its net asset value.

What is the ideal PB ratio to buy Parenteral Drugs (India) Ltd stocks?

An ideal PB ratio varies by industry; however, a PB ratio below 1.0 may indicate a good buying opportunity for Parenteral Drugs (India) Ltd. Some investors and financial analysts may also consider any value under 3.0 as a good PB ratio.

How is the PB Ratio of Parenteral Drugs (India) Ltd calculated?

The PB ratio of Parenteral Drugs (India) Ltd is calculated by dividing the current share price by the book value per share. The book value per share is determined by dividing the company’s total net assets (assets minus liabilities) by the number of outstanding shares. This ratio helps evaluate how the market values the company's assets.

What does a high PB Ratio mean for Parenteral Drugs (India) Ltd?

A high PB ratio suggests that Parenteral Drugs (India) Ltd’s stock may be overvalued relative to its book value or that investors expect high growth.

What does a low PB Ratio indicate for Parenteral Drugs (India) Ltd?

A low PB ratio of Parenteral Drugs (India) Ltd may indicate that the stock is undervalued or it is facing financial difficulties.

Can Parenteral Drugs (India) Ltd PB Ratio change over time?

Yes, the PB ratio of Parenteral Drugs (India) Ltd can change over time due to fluctuations in the company’s stock price and changes in its book value.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*